PROCEPT BioRobotics Co. (NASDAQ:PRCT – Get Free Report) has been given a consensus rating of “Buy” by the seven analysts that are presently covering the company, MarketBeat Ratings reports. Seven analysts have rated the stock with a buy recommendation. The average 12-month price objective among brokers that have updated their coverage on the stock in […]

Related Keywords

United States , Piper Sandler , Thomasm Krummel , Alaleh Nouri , Biorobotics Corporation , Blue Trust Inc , Jump Financial , Procept Biorobotics Co , Nasdaq , Securities Exchange Commission , Fairman Group , Get Free Report , Marketbeat Ratings , Truist Financial , Robotics Stock Down , Exchange Commission , Director Thomas , Jacobson Investment Advisors , Get Free , Robotics Corporation , Aquabeam Robotic System , Robotics Daily ,